<DOC>
	<DOCNO>NCT01751737</DOCNO>
	<brief_summary>This research study access use radiotracer , 18F-choline PET/CT MRI prostate cancer patient undergo diagnostic prostate biopsy . Patients receive MRI guide prostate biopsy metabolomic profile prostate biopsy tissue .</brief_summary>
	<brief_title>Choline PET/CT MRI Targeted Prostate Biopsy</brief_title>
	<detailed_description>This explorative diagnostic basic research study ass value 18F-choline PET/CT multi-sequence MRI prostate cancer patient undergo diagnostic prostate biopsy . Patients receive image-guided ( target ) prostate biopsy metabolomic profile prostate biopsy tissue evaluate underlie metabolic change comparison pathological Gleason grading .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Males 40 year age old schedule prostate biopsy ( know suspect prostate cancer ) follow plan prostatectomy ( population group A ) Males 40 year age old know ( biopsy‐confirmed ) primary adenocarcinoma prostate undergo active surveillance schedule prostate biopsy ( population group B ) Androgen ablation ( hormone treatment ) within last 3 month Prostate biopsy within 6 week prior PET MRI image Active inflammatory bowel disease within last 6 month Acute prostatitis within last 6 month A non‐urologic bacterial infection require active treatment antibiotic Active malignancy ( except basal cell squamous cell skin cancer ) within last 2 year Previous radiation treatment pelvis Symptomatic distal rectal stenosis Known hypersensitivity glucagon Pheochromocytoma , insulinoma galactosemia Insulin‐dependent diabetes</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>prostate</keyword>
	<keyword>cancer</keyword>
	<keyword>biopsy</keyword>
	<keyword>18F-choline</keyword>
	<keyword>PET</keyword>
	<keyword>MRI</keyword>
</DOC>